2021
DOI: 10.35814/jifi.v19i2.1107
|View full text |Cite
|
Sign up to set email alerts
|

Analisis Dampak Program Pengelolaan Penyakit Kronis (Prolanis) Dalam Meningkatkan Outcome Klinis Pasien Diabetes Melitus Tipe 2 Di Puskesmas Jakarta, Indonesia

Abstract: Prolanis adalah Program Manajemen Penyakit Kronis di bawah Jaminan Kesehatan Nasional Indonesia untuk mempromosikan dan mencegah penyakit kronis. Kegiatan utama program Prolanis adalah pengendalian dan konseling penyakit, pendidikan terjadwal, olahraga terjadwal, pengingat jadwal pasien, dan kunjungan rumah. Tujuan dari penelitian ini adalah untuk mengevaluasi dampak prolanis terhadap hasil klinis pada pasien Diabetes Melitus tipe 2 (DM). Penelitian secara observasional dan retrospektif. Data rekam medis diper… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
0
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 0 publications
0
0
0
1
Order By: Relevance
“…High levels of blood sugar markers indicate a poor prognosis. Studies show that PROLANIS participation is associated with a decrease in FBG (p0.003 (Dewi & Muflihatin, 2019)), (p0.002, r=-0.724 (Ahmad et al, 2017)) (p0.000 (Manninda et al, 2021;Primahuda & Sujianto, 2016;Rokhmad & Supriyanto, 2023;Setyawan et al, 2020)). There is a significant difference in FBG PROLANIS and NONPROLANIS (p=0.019) (Kristianto et al, 2021), a high number of participants with controlled GDP levels (54.63% and p0.034) (Larasati et al, 2020).…”
Section: Resultsmentioning
confidence: 99%
“…High levels of blood sugar markers indicate a poor prognosis. Studies show that PROLANIS participation is associated with a decrease in FBG (p0.003 (Dewi & Muflihatin, 2019)), (p0.002, r=-0.724 (Ahmad et al, 2017)) (p0.000 (Manninda et al, 2021;Primahuda & Sujianto, 2016;Rokhmad & Supriyanto, 2023;Setyawan et al, 2020)). There is a significant difference in FBG PROLANIS and NONPROLANIS (p=0.019) (Kristianto et al, 2021), a high number of participants with controlled GDP levels (54.63% and p0.034) (Larasati et al, 2020).…”
Section: Resultsmentioning
confidence: 99%
“…Apart from that, several factors such as limited resources in implementing Prolanis activities are obstacles to carrying out activities optimally (Salsabilah et al, 2023). There is also an impact on the quality of life that is still not significant for sufferers (Manninda et al, 2021). Low motivation to change a healthy lifestyle so they don't follow Prolanis (Solida et al, 2021).…”
Section: Resultsmentioning
confidence: 99%
“…Penelitian telah menunjukkan bahwa pengeloaan penyakit kronis yang baik dapat membantu mencegah atau memperlambat perkembangan komplikasi yang seringkali memerlukan perawatan yang mahal. Misalnya, pada penderita diabetes, pengendalian gula darah yang ketat telah terbukti mengurangi risiko komplikasi seperti gagal ginjal, kerusakan saraf, dan masalah mata, yang dapat mengurangi biaya perawatan jangka panjang (Manninda, Anggriani and Sari, 2021). Kedua, Prolanis berperan dalam mengatur peserta untuk menggunakan obat secara bijak.…”
Section: Tabel 2 Rekapitulasi Hasil Perhitungan Biaya Peserta Prolani...unclassified